Welcome to the Exercise Oncology/Oncology Nutrition (EON) Network!

Our goals:

  1. Support the research needed to develop evidence-based practice guidelines in both exercise oncology and oncology nutrition during cancer treatment
  2. Facilitate communication between the exercise oncology and oncology nutrition communities to achieve the joint goal of improving cancer treatment outcomes​​​​​
  3. Encourage communication between researchers and clinicians working with people receiving cancer treatment​​

We are excited to offer this new webinar series and networking opportunity, the Exercise Oncology/Oncology Nutrition (EON) Network, coordinated by the NCI-funded Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) Consortium.​​​​

 Fall 2026 Webinars

Wed, October 21st, 3:00 - 4:00 PM ET 

Diet and Chemotherapy-Induced Peripheral Neuropathy: Emerging Evidence, Future Directions

Chemotherapy-induced peripheral neuropathy (CIPN) is a significant side effect of certain types of chemotherapies that impacts quality of life and treatment tolerance. Emerging observational evidence has highlighted the relationship between diet and the development and reduction of CIPN. This presentation will discuss this existing body of evidence and the mechanisms by which diet may impact CIPN, particularly CIPN caused by platinum-based chemotherapies. This presentation will also present an upcoming randomized control trial investigating diet to delay CIPN development and explore future directions.

This EON webinar awards 1.0 CPEU for Commission on Dietetic Registration (CDR) credentialed practitioners in accordance with the Commission on Dietetic Registration’s CPEU Prior Approval Program. 

The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for physicians, physician assistants, and nurse practitioners.

Speaker Background

Stephanie L.E. Compton, Ph.D., RD is a Postdoctoral Research Fellow and Registered Dietitian in the Exercise and Cancer Biology Research Program at AdventHealth Translational Research Institute. Her research examines how nutrition and physical activity impact cancer survivors’ cancer treatment tolerance, chronic disease risk, quality of life, and overall survival. Dr. Compton has received grants from the American Cancer Society, American Institute for Cancer Research, and the National Cancer Institute. She is currently supported by a K99/R00 Pathway to Independence Award from the National Cancer Institute, which is investigating the role of diet in the development of chemotherapy-induced peripheral neuropathy. ​​​​​​​


Wed, December 2nd, 2:00 - 3:00 PM ET 

The GLP-1 Era in Cancer Care: From Emerging Evidence to Clinical Practice

This presentation will examine the evolving role of GLP-1 receptor agonists in cancer care, including proposed direct and indirect mechanisms through which they may influence cancer biology and health outcomes. It will review observational evidence and emerging clinical trials across cancer types, discuss implications for clinical practice, and identify key unanswered questions and priorities for future oncology research.

The George Washington University School of Medicine and Health Sciences is pending approval for this live activity to offer a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for physicians, physician assistants, and nurse practitioners.

Speaker Background

Jasmine Sukumar, MD is an Assistant Professor in the Department of Breast Medical Oncology at MD Anderson. She completed the dual BA/MD program at the University of Missouri-Kansas City followed by internal medicine residency at the University of Texas Southwestern Medical Center in Dallas. She subsequently joined The Ohio State University Comprehensive Cancer Center for medical oncology fellowship and breast cancer focused subspecialty training. She then completed a postdoctoral fellowship in breast cancer control and metabolic health. She was also competitively selected for 2021 TREC Workshop, an NIH-funded research training program through the Yale School of Public Health for investigators in energetics and transdisciplinary cancer research. She has received national grant funding through an Conquer Cancer Foundation, The NIH (K12 program), and the Robert A Winn Excellence in Clinical Trials Career Develop Award. She has published in peer reviewed journals such as Cancers, JCO Oncology Practice, and Breast Cancer Research and Treatment. In addition to treating patients with breast cancer, she is a clinical investigator with a focus on energy balance and cancer; this includes body composition and lifestyle behaviors in the context of breast cancer survivorship and risk reduction. Her goal is to design personalized lifestyle intervention that will lead to improvements in weight loss and physical functioning, ultimately positively impacting quality of life and cancer risk in breast cancer patients.